Iradimed IRMD Insider Ownership

NASDAQ IRMD

$87.81 -0.43 (-0.49%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

2.26Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

34.99%

▼-0.0056% pp QoQ

Shares Held by Insiders

4.47Mn

filed for Sep 2026

▼-0.02% QoQ

Shares Outstanding

12.78Mn

12,784,000 shares

Direct Holdings

85.33K

Indirect: 4.39Mn

Net Shares Traded (QoQ)

-721

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 16, 2026

Across the past 12 months, open-market trades by Iradimed insiders were all sales, totaling $19.62 million (212.07K shares).

Behind Iradimed's open-market sales in the past 12 months were 5 insiders, and no insider bought.
Roger E. Susi (CEO, President, Chairman) led open-market sales of Iradimed stock over the past 12 months with $16.2 million (175K shares), most recently on June 1, 2026.
The latest open-market trade in IRMD stock by an insider was a sale of 1.42K shares for $122,622 by Monty K. Allen (Director) on September 3, 2026.
Outside the open market, Iradimed insiders acquired 42.92K shares through option exercises and conversions and gave up 14.99K shares to cover taxes or exercise prices over the past 12 months.
Business Quant data shows Iradimed insiders holding 4.47Mn shares in total in their latest Form 4 filings, down 0.02% from 4.47Mn shares at the end of Q2 2026 and down 4.32% from 4.68Mn shares at the end of Q3 2025.
Of the 4.47Mn shares held by Iradimed insiders, 85.33K shares (1.91%) are held directly and 4.39Mn shares (98.09%) indirectly, through trusts, partnerships, family members and other entities.
The insider holdings in Iradimed belong to 8 insiders who have reported on Form 4 within the past two years.
Iradimed's three largest insider shareholders, based on their latest Form 4 filings, are Roger E. Susi (CEO, President, Chairman, 4.39Mn shares), James B. Hawkins (Director, 29.65K shares) and Monty K. Allen (Director, 19.58K shares).
The holding of Roger E. Susi makes up 98.09% of all shares held by Iradimed insiders.
Institutional investors held 61.24% of Iradimed stock at the end of Q2 2026, while the latest Form 4 filings of its insiders account for about 34.99%; other investors, including the public, hold roughly 3.77%.
In the past year, 7 insiders of Iradimed submitted 51 Form 4 filings reporting trades, awards or other transactions.
The insider holdings and trades above for Iradimed reflect Form 4 filings through September 25, 2026.

Form 4 Holdings

Insiders Holding IRMD

Insiders 9

Shares held 2.26Mn

Of outstanding 17.69%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Roger E. Susi	Ceo, President, Chairman	0	2,162,500	2,162,500	95.6%	02 Jun, 2026
2	James B Hawkins	Director	29,647	0	29,647	1.3%	12 Dec, 2025
3	Monty K Allen	Director	19,581	0	19,581	0.9%	08 Sep, 2026
4	Anthony Vuoto	Director	17,181	0	17,181	0.8%	10 Dec, 2024
5	Christopher K. Scott	Cfo Secretary	13,710	0	13,710	0.6%	11 Feb, 2022
6	John Glenn	Cfo	11,937	0	11,937	0.5%	23 Jun, 2026
7	Hilda Frederique Scharen-Guivel	Director	5,598	0	5,598	0.2%	04 Jun, 2026
8	Joe E Kiani	Director	698	0	698	0.0%	25 Sep, 2026
9	Jeff Chiprin	Chief Commercial Officer	687	0	687	0.0%	12 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,562 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
23 Sep, 2026	Joe E Kiani	Director	Acquired M	698	—	—	698	Direct
23 Sep, 2026	Joe E Kiani	Director	Disposed M	698	$0.00	$0	1,397	Direct
03 Sep, 2026	Monty K Allen	Director	Disposed S	1,014	$86.44	$87.65K	19,986	Direct
03 Sep, 2026	Monty K Allen	Director	Disposed S	405	$86.35	$34.97K	19,581	Direct
20 Jun, 2026	John Glenn	Cfo	Acquired M	5,796	—	—	14,256	Direct
20 Jun, 2026	John Glenn	Cfo	Disposed F	2,319	$92.20	$213.81K	11,937	Direct
20 Jun, 2026	John Glenn	Cfo	Disposed M	5,796	$0.00	$0	0	Direct
04 Jun, 2026	Hilda Frederique Scharen-Guivel	Director	Disposed S	1,766	$95.00	$167.77K	6,832	Direct
04 Jun, 2026	Hilda Frederique Scharen-Guivel	Director	Disposed S	1,234	$95.00	$117.23K	5,598	Direct
01 Jun, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	400	$88.68	$35.47K	2,164,600	Indirect
01 Jun, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	775	$89.79	$69.59K	2,163,825	Indirect
01 Jun, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	401	$91.08	$36.52K	2,163,424	Indirect
01 Jun, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	924	$91.91	$84.92K	2,162,500	Indirect
26 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	3,111	$91.81	$285.62K	2,169,389	Indirect
26 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	1,889	$92.93	$175.54K	2,167,500	Indirect
27 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	2,167	$91.85	$199.04K	2,165,333	Indirect
27 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	333	$92.61	$30.84K	2,165,000	Indirect
18 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	298	$85.95	$25.61K	2,179,702	Indirect
18 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	3,451	$87.35	$301.44K	2,176,251	Indirect
18 May, 2026	Roger E. Susi	Ceo, President, Chairman	Disposed S	1,251	$88.34	$110.51K	2,175,000	Indirect

Showing 1 to 20 of 1,562 transactions